InsiderTrades

Form 4 for TKR TIMKEN CO

Accepted 2022-11-08 00:00:00 ET · period of report 2022-11-04 · accession 0000098362-22-000122 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2022-11-08 2022-11-04 TKR Fracassa Philip D. EVP, CFO S - Sale+OE $71.39 -16.3K 85.7K -16% -$1.16M
D 2022-11-08 2022-11-04 TKR Fracassa Philip D. EVP, CFO F - Tax $71.10 -3,092 102.0K -3% -$219.8K
D 2022-11-08 2022-11-04 TKR Fracassa Philip D. EVP, CFO M - OptEx $44.65 +19.4K 105.1K +23% +$866.2K
D 2022-11-08 2022-11-04 TKR Fracassa Philip D. EVP, CFO M - OptEx $0.00 -19.4K 0 -100% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2022-11-04 S D 6,184 $70.86 95,783 D — — (F1) This transaction was executed in multiple trades at prices ranging from $70.25 to $71.19. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
2 Common Common Stock 2022-11-04 S D 10,124 $71.72 85,659 D — — (F2) This transaction was executed in multiple trades at prices ranging from $71.31 to $72.03. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
3 Common Common Stock 2022-11-04 F D 3,092 $71.10 101,967 D — —
4 Common Common Stock 2022-11-04 M A 19,400 $44.65 105,059 D — —
5 Derivative Employee Stock Options (right to buy) 2022-11-04 M D 19,400 $0.00 0 D $44.65 · 2019-02-12 to 2028-02-12 19,400 Common Stock (F3) 19,400 stock options from 2/12/2018 grant of 29,400 stock options (previously reported) that vested in 25% increments per year from the date of grant.